1916 related articles for article (PubMed ID: 32811406)
1. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
[TBL] [Abstract][Full Text] [Related]
2. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
3. Cell and animal models of SARS-CoV-2 pathogenesis and immunity.
Leist SR; Schäfer A; Martinez DR
Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32887790
[TBL] [Abstract][Full Text] [Related]
4. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Martinez MA
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
[TBL] [Abstract][Full Text] [Related]
5. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.
Shih HI; Wu CJ; Tu YF; Chi CY
Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
mBio; 2020 May; 11(3):. PubMed ID: 32444382
[TBL] [Abstract][Full Text] [Related]
7. Tackling SARS-CoV-2: proposed targets and repurposed drugs.
Joshi S; Joshi M; Degani MS
Future Med Chem; 2020 Sep; 12(17):1579-1601. PubMed ID: 32564623
[TBL] [Abstract][Full Text] [Related]
8. Emerging prophylaxis strategies against COVID-19.
Agrawal S; Goel AD; Gupta N
Monaldi Arch Chest Dis; 2020 Mar; 90(1):. PubMed ID: 32231348
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 - Toward a comprehensive understanding of the disease.
Kowalik MM; Trzonkowski P; Łasińska-Kowara M; Mital A; Smiatacz T; Jaguszewski M
Cardiol J; 2020; 27(2):99-114. PubMed ID: 32378729
[TBL] [Abstract][Full Text] [Related]
10. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
[TBL] [Abstract][Full Text] [Related]
11. Vaccine development and therapeutic design for 2019-nCoV/SARS-CoV-2: Challenges and chances.
Ghaebi M; Osali A; Valizadeh H; Roshangar L; Ahmadi M
J Cell Physiol; 2020 Dec; 235(12):9098-9109. PubMed ID: 32557648
[TBL] [Abstract][Full Text] [Related]
12. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 challenge for modern medicine.
Dzieciatkowski T; Szarpak L; Filipiak KJ; Jaguszewski M; Ladny JR; Smereka J
Cardiol J; 2020; 27(2):175-183. PubMed ID: 32286679
[TBL] [Abstract][Full Text] [Related]
14. COVID-19: Small-Molecule Clinical Trials Landscape.
Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
[No Abstract] [Full Text] [Related]
15. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
16. Emergence of novel coronavirus and progress toward treatment and vaccine.
Khan MM; Noor A; Madni A; Shafiq M
Rev Med Virol; 2020 Jul; 30(4):e2116. PubMed ID: 32495979
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
18. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19.
Samudrala PK; Kumar P; Choudhary K; Thakur N; Wadekar GS; Dayaramani R; Agrawal M; Alexander A
Eur J Pharmacol; 2020 Sep; 883():173375. PubMed ID: 32682788
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics.
Amawi H; Abu Deiab GI; A Aljabali AA; Dua K; Tambuwala MM
Ther Deliv; 2020 Apr; 11(4):245-268. PubMed ID: 32397911
[TBL] [Abstract][Full Text] [Related]
20. Immune-mediated approaches against COVID-19.
Florindo HF; Kleiner R; Vaskovich-Koubi D; Acúrcio RC; Carreira B; Yeini E; Tiram G; Liubomirski Y; Satchi-Fainaro R
Nat Nanotechnol; 2020 Aug; 15(8):630-645. PubMed ID: 32661375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
